Abbott Laboratories Statement of Changes in Director/PDMR Shareholding (1449L)
September 29 2016 - 2:00AM
UK Regulatory
TIDMABT
RNS Number : 1449L
Abbott Laboratories
28 September 2016
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS
BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES
AND PERSONS CLOSELY ASSOCIATED WITH THEM
Details of the person discharging managerial
1. responsibilities/person closely associated
a) Name Daniel Gesua Sive Salvadori
------------------------ --------------------------------------
2. Reason for the notification
Senior Vice President, Established
a) Position / status Pharmaceuticals, Latin America
------------------------ --------------------------------------
Initial notification
b) / amendment Initial Notification
------------------------ --------------------------------------
Details of the issuer, emission allowance
market participant, auction platform, auctioneer
3. or auction monitor
a) Name Abbott Laboratories
------------------------ ------------------------- -----------
b) LEI HQD377W2YR662HK5JX27
------------------------ ------------------------- -----------
Details of the transaction(s)
Section to be repeated for (i) each type
of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where
4. transactions have been conducted
Description
of the financial
instrument, Common Shares without par
a) type of instrument value
------------------------ --------------------------------------
Identification
code US0028241000
------------------------ --------------------------------------
Nature of the Disposal of shares in payment
b) transaction of tax liability
------------------------ --------------------------------------
Price(s) Volume(s)
------------------------ ------------------------- -----------
c) USD 42.19 2,001
------------------------ -----------
Aggregated information
--------------------------------------
- Aggregated
volume
--------------------------------------
d) - Price
------------------------ --------------------------------------
Date of the
e) transaction 2016-09-26
------------------------ --------------------------------------
Place of the
f) transaction New York Stock Exchange (XNYS)
------------------------ --------------------------------------
Details of the transaction(s)
Section to be repeated for (i) each type
of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where
5 transactions have been conducted
Description
of the financial
instrument, Common Shares without par
a) type of instrument value
------------------------ --------------------------------------
Identification
code US0028241000
------------------------ --------------------------------------
Nature of the
b) transaction Sale of ABT Securities
------------------------ --------------------------------------
Price(s) Volume(s)
------------------------ ------------------------- -----------
c) USD 41.711 815
------------------------ -----------
Aggregated information
----------------
- Aggregated
volume
----------------
d) - Price
--------------------------------------------------- -----------
Date of the
e) transaction 2016-09-26
------------------------ --------------------------------------
Place of the
f) transaction New York Stock Exchange (XNYS)
------------------------ --------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHEAFNPAFSKEAF
(END) Dow Jones Newswires
September 29, 2016 02:00 ET (06:00 GMT)
Abbott Labs (LSE:ABT)
Historical Stock Chart
From Apr 2024 to May 2024
Abbott Labs (LSE:ABT)
Historical Stock Chart
From May 2023 to May 2024
